Viewing Study NCT02420366


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-01-26 @ 1:19 AM
Study NCT ID: NCT02420366
Status: COMPLETED
Last Update Posted: 2018-05-02
First Post: 2015-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module